From: Histone acetylation: a key determinant of acquired cisplatin resistance in cancer
Gene | GeneID | Forward (5′–3′) | Reverse (5′–3′) |
---|---|---|---|
PIK3CA | 5290 | TTGTCGTGCATGTGGGATGT | CTGGTCGCCTCATTTGCTCA |
PIK3CB | 5291 | GTAGACTGGGCCTTTGGAACTT | TGATGAGGCTGGGAAACAAGG |
PIK3R1 | 5295 | CCTGGCCTGAGAAGGTTTGG | GTCCCTTGTGAGTGGACGTG |
HK2 | 3099 | TTGACCAGGAGATTGACATGGG | CAACCGCATCAGGACCTCA |
ENO1 | 2023 | GTACATCTCGCCTGACCAGC | CTGGCTGTGAACTTCTGCCA |
XIAP | 331 | ACGGGCTAAGGTAGGGTAGAG | CTAATGCTGGGGCGGTAGTC |
BCL-XL | 598 | TGCCACCAGGAGAACCACTA | TCTGAGGCCAAGGGAACTGA |
HDAC1 | 3065 | ATATCGTCTTGGCCATCCTG | TGAAGCAACCTAACCGATCC |
HDAC2 | 3066 | GGGAATACTTTCCTGGCACA | ACGGATTGTGTAGCCACCTC |
HDAC3 | 8841 | TGGCATTGACCCATAGCCTG | GCATATTGGTGGGGCTGACT |
HDAC4 | 9759 | TCGCTACTGGTACGGGAAAAC | AGAGGGAAGTCATCTTTGGCG |
HDAC5 | 10014 | ACTGTTCTCAGATGCCCAGC | TGGTGAAGAGGTGCTTGACG |
HDAC6 | 10013 | AGTGGCCGCATTATCCTTATCC | ATCTGCGATGGACTTGGATGG |
HDAC7 | 51564 | TTCCTGAGTGCAGGGGTAGT | CATCGCCAGGAGGTTGATGT |
HDAC8 | 55869 | ATAACCTTGCCAACACGGCT | CTTGGCGTGATTTCCAGCAC |
HDAC9 | 9734 | ACTGAAGCAACCAGGCAGTC | TTCACAGCCCCAACTTGTCC |
HDAC10 | 83933 | CTGGCCTTTGAGGGGCAAAT | CAGCAGCGTCTGTACTGTCA |
HDAC11 | 79885 | CCGGAAAATGGGGCAAAGTG | TAAGATAGCGCCTCGTGTGC |
HAT1 | 8520 | AATGGCGGGATTTGGTGCTA | TCATCCCCAAAGAGTTGATGGG |
KAT2A | 2648 | TCGAGTTCCATGTCATCGGC | TCAAGGCCAGAGTCTTGTGC |
KAT2B | 8850 | GAATCGCCGTGAAGAAAGCG | TTATTTGCTGCAGGTCGGCT |
KAT5 | 10524 | AGCGTGAAGGACATCAGTGG | AGTCCGTTCTTAGTGGGGGT |
CREBBP | 1387 | TGTTTTCGCGAGCAGGTGA | GTGCTGTCATTCGCCGAGA |
EP300 | 2033 | GCAGTGTGCCAAACCAGATG | GGGTTTGCCGGGGTACAATA |
KAT8 | 84148 | TCGGAGAAACGTACCTGTGC | TCTTGTCTACCCACTCGTCCA |
RPS13 | 6207 | GCTCTCCTTTCGTTGCCTGA | ACTTCAACCAAGTGGGGACG |